Francis Dominic Sanderson

This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignees: Smithkline Beecham Corporation, Glaxo Group Limited, Glaxosmithkline LLC. Active years: 2001-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francis Dominic Sanderson. Retrieved from https://idiyas.com/inventor/francis-dominic-sanderson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 5

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 23(Granted Patents)

Company Filing History:

3 out of 2,198

Smithkline Beecham Corporation

where one patent can have more than one assignee

Years Active: 2001-2012

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8207191 - Process, salts, composition and use (2012-06-26),

2. RE43390 - Pleuromutilin derivatives as antimicrobials (2012-05-14),

3. 7875630 - Process salts compositions and use (2011-01-25),

4. RE39128 - Pleuromutilin derivatives as antimicrobials (2006-06-12),

5. 6281226 - Pleuromutilin derivatives as antimicrobials (2001-08-28),

Title: Spotlight on Inventor Francis Dominic Sanderson

Introduction:

Francis Dominic Sanderson is a notable inventor based in Harlow, GB, with a total of 5 patents to his name. His innovative work in the field of medical therapy, particularly antibacterial therapy, has garnered him recognition in the industry.

Latest Patents:

Sanderson's latest patents showcase his expertise in developing novel processes and compositions for medical treatments. One of his patents involves pleuromutilin derivatives for use as antimicrobials, highlighting his focus on addressing bacterial infections effectively.

Career Highlights:

Throughout his career, Sanderson has made significant contributions to companies such as SmithKline Beecham Corporation and Glaxo Group Limited. His dedication to advancing pharmaceutical solutions has led to the successful creation of patents that have the potential to impact the medical field positively.

Collaborations:

During his professional journey, Sanderson has had the privilege of collaborating with talented individuals in the industry. Notably, he has worked alongside coworkers such as Valerie Joan Berry and Steven Dabbs, who have contributed to the success of various projects.

Conclusion:

In conclusion, Francis Dominic Sanderson's commitment to innovation and his passion for improving medical therapy shine through in his patent portfolio. His inventive spirit and collaborative approach make him a valuable asset to the field of pharmaceuticals, inspiring continued advancements in antibacterial treatments.

Profile summary based on public USPTO records.